EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Regulatory news and changes

What dates should buyers put in the forward calendar?

Dose Diligence research deskSection 04 · Page 14 of 17Last updated 17 Nov 2026
DateActual eventProcurement implication
November 27, 2026Staffing measurement date for the new small-dispenser exemptionRecord corporate-level eligibility; do not confuse it with the extended exemption’s end date. (fda.gov)
December 31, 2026End of FDA’s FY2027 outsourcing-facility registration window; FY2026 registrations expireObtain updated registration evidence for any relevant 503B partner. Registration remains separate from product eligibility. (fda.gov)
January 1, 2027Last state-entry date currently stated for Medicaid BALANCEVerify target-state participation and implementation; this is not a clinic enrolment deadline. (cms.gov)
November 27, 2027Stated end of the specified small-dispenser DSCSA exemptionsMaintain an implementation plan rather than postponing all traceability work. (fda.gov)
December 31, 2027Current scheduled end of Medicare GLP-1 BridgeInclude coverage-transition monitoring in partner responsibilities. (cms.gov)
Explore the table row by row

A working view of the research

November 27, 2026

Actual event
Staffing measurement date for the new small-dispenser exemption
Procurement implication
Record corporate-level eligibility; do not confuse it with the extended exemption’s end date. (fda.gov)

Sources cited on this page

  1. fda.gov · Source 1 ↗https://www.fda.gov/drugs/drug-supply-chain-security-act-dscsa/exemptions-under-drug-supply-chain-security-act
  2. fda.gov · Source 2 ↗https://www.fda.gov/industry/fda-user-fee-programs/human-drug-compounding-outsourcing-facility-fees?utm_source=openai
  3. cms.gov · Source 3 ↗https://www.cms.gov/priorities/innovation/innovation-models/balance
  4. cms.gov · Source 4 ↗https://www.cms.gov/files/document/status-update-bridge-demo-balance-model-part-d-cy2027-g-pdf.pdf
Section sources →